Stemtech forms joint venture to enter Indian market

NAPLES, FL - Stemtech Corporation (OTCQB:STEK) announced Thursday a strategic agreement to establish a joint venture in India with Innoventure Dynamic LLP. The new entity, Stemtech HealthSciences India Private Limited, will be 51% owned by Stemtech and 49% by Innoventure Dynamic. According to InvestingPro data, Stemtech maintains impressive gross profit margins of 75.9%, though the company faces challenges with its current market capitalization of $690,000.

According to the press release, the India-based startup will be entirely funded by the Indian partner while operating under Stemtech’s corporate structure. The joint venture aims to introduce Stemtech’s stem cell nutrition products to the Indian market. This expansion comes as the company works to improve its financial position, with InvestingPro analysis showing annual revenue of $3.91 million and indicating the stock is currently trading near its 52-week low.

"India has always been a large market of interest for us," said Charles S. Arnold, Stemtech’s Chairman and CEO, in the company statement. The venture will focus on distributing Stemtech’s product line including nutritional supplements, skin care, oral care, and pet products.

David Das, Director of Innoventure Dynamic LLP, will partner with Stemtech’s President and COO John W. Meyer, who will serve as Managing Director of the new Indian entity. Meyer noted that the company eventually plans to manufacture its products in India.

The joint venture partners indicated they see potential for expansion beyond India into Gulf Cooperation Council countries, including Saudi Arabia, Kuwait, the United Arab Emirates, Qatar, Bahrain, and Oman. With revenue declining 27.1% over the last twelve months, this expansion could be crucial for the company’s growth. InvestingPro subscribers have access to 13 additional investment tips and comprehensive financial analysis for STEK, helping investors make more informed decisions about the company’s expansion strategy.

Stemtech Corporation describes itself as a pioneer in stem cell nutrition with a direct sales distribution model. The company went public in August 2021 and recently launched pet nutrition products in June 2025. The company’s financial health score from InvestingPro currently indicates challenges, with short-term obligations exceeding liquid assets and a current ratio of 0.11.

Innoventure Dynamic LLP, headquartered in New Delhi, is a strategic consulting and business development firm with operations in the UAE and Denmark.

The information in this article is based on a press release statement from Stemtech Corporation.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.